Primary infection of mice with high titer inoculum respiratory syncytial virus:: characterization and response to antiviral therapy (vol 83, pg 198, 2005)

被引：0
|
作者：
Bolger, G
Lapeyre, N
Dansereau, N
Lagacé, L
Berry, G
Klosowski, K
Mewhort, T
Liuzzi, M
机构：
[1] Boehringer Ingelheim Canada Ltd, Res & Dev, Dept Biol Sci, Laval, PQ H7S 2G5, Canada
[2] St Marys Hosp, Dept Pathol, Montreal, PQ H3T 1M5, Canada
来源：
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2005年 / 83卷 / 03期
关键词：
D O I：
10.1139/Y05-904
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：319 / 319
页数：1
相关论文
共 9 条
  • [1] Primary infection of mice with high titer inoculum respiratory syncytial virus:: characterization and response to antiviral therapy
    Bolger, G
    Lapeyre, N
    Dansereau, N
    Lagacé, L
    Berry, G
    Klosowski, K
    Mewhort, T
    Liuzzi, M
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2005, 83 (02) : 198 - 213
  • [2] Cytokine amplification by respiratory syncytial virus infection in human nasal epithelial cells (vol 115, pg 764, 2005)
    Das
    LARYNGOSCOPE, 2005, 115 (11): : 2076 - 2076
  • [3] Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans
    Sun, Yan
    Jain, Deepika
    Koziol-White, Cynthia J.
    Genoyer, Emmanuelle
    Gilbert, Micah
    Tapia, Karla
    Panettieri, Reynold A., Jr.
    Hodinka, Richard L.
    Lopez, Carolina B.
    PLOS PATHOGENS, 2015, 11 (09) : 1 - 21
  • [4] Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice (vol 204, pg 987, 2011)
    Quan, Fu-Shi
    Kim, Yonghwan
    Lee, Sujin
    Yi, Hong
    Kang, Sang-Moo
    Bozja, Jadranka
    Moore, Martin L.
    Compans, Richard W.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (03): : 520 - 520
  • [5] Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene (vol 11, pg 56, 2005)
    Zhang, W
    Yang, H
    Kong, X
    Mohapatra, S
    San Juan-Vergara, H
    Hellermann, G
    Behera, S
    Singam, R
    Lockey, RF
    Mohapatra, SS
    NATURE MEDICINE, 2005, 11 (02) : 233 - 233
  • [6] Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization (vol 38, pg 1016, 2008)
    Tourdot, S.
    Mathie, S.
    Hussell, T.
    Edwards, L.
    Wang, H.
    Openshaw, P. J. M.
    Schwarze, J.
    Lloyd, C. M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2008, 38 (07): : 1241 - 1241
  • [7] Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations (vol 11, pg 208, 2009)
    Weisman, Leonard E.
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2009, 11 (03) : 346 - 347
  • [8] Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice
    Lukens, Michael V.
    Claassen, Erwin A. W.
    de Graaff, Patricia M. A.
    van Dijk, Maniska E. A.
    Hoogerhout, Peter
    Toebes, Mireille
    Schumacher, Ton N.
    van der Most, Robbert G.
    Kimpen, Jan L. L.
    van Bleek, Grada M.
    VIROLOGY, 2006, 352 (01) : 157 - 168
  • [9] Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection
    Rutigliano, JA
    Johnson, TR
    Hollinger, TN
    Fischer, JE
    Aung, S
    Graham, BS
    JOURNAL OF VIROLOGY, 2004, 78 (06) : 3014 - 3023
1